| AstraZeneca (AZN) |
United Kingdom |
$291.540B |
20.57 |
| Amgen (AMGN) |
United States |
$177.715B |
15.09 |
| Gilead Sciences (GILD) |
United States |
$150.445B |
14.81 |
| Bristol Myers Squibb (BMY) |
United States |
$115.264B |
8.63 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$111.362B |
28.67 |
| GSK (GSK) |
United Kingdom |
$100.127B |
11.09 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$77.975B |
20.23 |
| CSL (CSLLY) |
Australia |
$56.805B |
0.00 |
| Argenex SE (ARGX) |
Netherlands |
$50.070B |
62.17 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$47.463B |
1562.00 |
| Insmed (INSM) |
United States |
$33.968B |
0.00 |
| Biogen (BIIB) |
United States |
$24.730B |
10.07 |
| BioNTech SE (BNTX) |
Germany |
$23.885B |
0.00 |
| Revolution Medicines (RVMD) |
United States |
$23.831B |
0.00 |
| Royalty Pharma (RPRX) |
United States |
$22.928B |
8.79 |
| Genmab (GNMSF) |
Denmark |
$22.218B |
16.30 |
| Illumina (ILMN) |
United States |
$22.202B |
33.33 |
| Genmab (GMAB) |
Denmark |
$21.745B |
16.35 |
| Incyte (INCY) |
United States |
$20.661B |
19.78 |
| Exact Sciences (EXAS) |
United States |
$19.528B |
538.63 |
| Roivant Sciences (ROIV) |
United Kingdom |
$16.205B |
0.00 |
| Moderna (MRNA) |
United States |
$15.379B |
0.00 |
| Regencell Bioscience Holdings (RGC) |
Hong Kong, SAR China |
$14.864B |
0.00 |
| Guardant Health (GH) |
United States |
$14.114B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$13.328B |
0.00 |
| Swedish Orphan Biovitrum (BIOVF) |
Sweden |
$13.172B |
24.50 |
| Exelixis (EXEL) |
United States |
$12.183B |
19.50 |
| Avidity Biosciences (RNA) |
United States |
$10.939B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$10.901B |
40.67 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$10.580B |
19.19 |
| Jazz Pharmaceuticals (JAZZ) |
Ireland |
$10.401B |
40.56 |
| QIAGEN (QGEN) |
Netherlands |
$10.217B |
19.39 |
| Abivax SA (ABVX) |
France |
$9.102B |
0.00 |
| Repligen (RGEN) |
United States |
$9.102B |
97.40 |
| Arrowhead Pharmaceuticals (ARWR) |
United States |
$9.002B |
0.00 |
| Axsome Therapeutics (AXSM) |
United States |
$8.779B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$8.446B |
13.50 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$8.381B |
30.14 |
| Krystal Biotech (KRYS) |
United States |
$8.178B |
42.28 |
| Cytokinetics (CYTK) |
United States |
$7.756B |
0.00 |
| Nuvalent (NUVL) |
United States |
$7.719B |
0.00 |
| Praxis Precision Medicines (PRAX) |
United States |
$7.502B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$7.078B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$6.960B |
0.00 |
| Merus (MRUS) |
Netherlands |
$6.826B |
0.00 |
| Vaxcyte (PCVX) |
United States |
$6.289B |
0.00 |
| PTC Therapeutics (PTCT) |
United States |
$6.073B |
8.25 |
| Belite Bio (BLTE) |
United States |
$5.613B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$5.588B |
0.00 |
| Apogee Therapeutics (APGE) |
United States |
$5.517B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$5.298B |
136.69 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$5.166B |
0.00 |
| Structure Therapeutics (GPCR) |
United States |
$5.159B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$5.155B |
15.15 |
| Kymera Therapeutics (KYMR) |
United States |
$5.117B |
0.00 |
| Anbio Biotechnology (NNNN) |
Germany |
$4.977B |
0.00 |
| TG Therapeutics (TGTX) |
United States |
$4.876B |
11.05 |
| Celcuity (CELC) |
United States |
$4.871B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$4.746B |
0.00 |
| Mirum Pharmaceuticals (MIRM) |
United States |
$4.745B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$4.637B |
4.70 |
| Immunovant (IMVT) |
United States |
$4.557B |
0.00 |
| Akero Therapeutics (AKRO) |
United States |
$4.499B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$4.488B |
37.90 |
| Amicus Therapeutics (FOLD) |
United States |
$4.415B |
357.75 |
| CG Oncology (CGON) |
United States |
$4.281B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$4.165B |
29.66 |
| Legend Biotech (LEGN) |
United States |
$4.083B |
0.00 |
| Arcellx (ACLX) |
United States |
$3.950B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$3.891B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$3.859B |
94.72 |
| GRAIL (GRAL) |
United States |
$3.798B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$3.604B |
0.00 |
| Liquidia (LQDA) |
United States |
$3.375B |
0.00 |
| Terns Pharmaceuticals (TERN) |
United States |
$3.331B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$3.252B |
0.00 |
| Arcutis Biotherapeutics (ARQT) |
United States |
$3.229B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$3.161B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$3.152B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$3.148B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
United States |
$3.126B |
0.00 |
| Vera Therapeutics (VERA) |
United States |
$2.959B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
United Kingdom |
$2.874B |
84.27 |
| Edgewise Therapeutics (EWTX) |
United States |
$2.816B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$2.754B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$2.714B |
0.00 |
| Erasca (ERAS) |
United States |
$2.712B |
0.00 |
| Disc Medicine (IRON) |
United States |
$2.682B |
0.00 |
| HUTCHMED (China) (HCM) |
Hong Kong, SAR China |
$2.671B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$2.598B |
66.23 |
| Spyre Therapeutics (SYRE) |
United States |
$2.568B |
0.00 |
| Ascentage Pharma Group - (AAPG) |
China |
$2.548B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$2.541B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$2.529B |
0.00 |
| Alumis (ALMS) |
United States |
$2.523B |
0.00 |
| Telix Pharmaceuticals (TLX) |
Australia |
$2.517B |
0.00 |
| Mineralys Therapeutics (MLYS) |
United States |
$2.483B |
0.00 |
| Bavarian Nordic (BVNRY) |
Denmark |
$2.432B |
6.60 |
| Recursion Pharmaceuticals (RXRX) |
United States |
$2.412B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.353B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$2.352B |
0.00 |
| Mesoblast (MESO) |
Australia |
$2.275B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$2.267B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$2.233B |
0.00 |
| Zai Lab (ZLAB) |
China |
$2.107B |
0.00 |
| Nuvation Bio (NUVB) |
United States |
$2.105B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$2.097B |
11.45 |
| Immunome (IMNM) |
United States |
$2.096B |
0.00 |
| Olema Pharmaceuticals (OLMA) |
United States |
$2.004B |
0.00 |
| Vericel (VCEL) |
United States |
$1.951B |
160.71 |
| ANI Pharmaceuticals (ANIP) |
United States |
$1.916B |
14.86 |
| Maze Therapeutics (MAZE) |
United States |
$1.916B |
0.00 |
| MBX Biosciences (MBX) |
United States |
$1.837B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.834B |
53.86 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$1.797B |
0.00 |
| Zymeworks (ZYME) |
United States |
$1.768B |
0.00 |
| Sionna Therapeutics (SION) |
United States |
$1.734B |
0.00 |
| MannKind (MNKD) |
United States |
$1.713B |
55.80 |
| Celldex Therapeutics (CLDX) |
United States |
$1.707B |
0.00 |
| Stoke Therapeutics (STOK) |
United States |
$1.672B |
43.70 |
| Upstream Bio (UPB) |
United States |
$1.670B |
0.00 |
| NeoGenomics (NEO) |
United States |
$1.660B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.655B |
0.00 |
| Agios Pharmaceuticals (AGIO) |
United States |
$1.621B |
0.00 |
| Tango Therapeutics (TNGX) |
United States |
$1.574B |
0.00 |
| Monte Rosa Therapeutics (GLUE) |
United States |
$1.568B |
75.25 |
| Tyra Biosciences (TYRA) |
United States |
$1.549B |
0.00 |
| NovoCure (NVCR) |
Jersey |
$1.545B |
0.00 |
| Certara (CERT) |
United States |
$1.516B |
28.00 |
| Alvotech (ALVO) |
Luxembourg |
$1.492B |
21.52 |
| Mind Medicine (MindMed) (MNMD) |
United States |
$1.480B |
0.00 |
| Fortrea Holdings (FTRE) |
United States |
$1.475B |
31.29 |
| Precigen (PGEN) |
United States |
$1.465B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.450B |
0.00 |
| Kodiak Sciences (KOD) |
United States |
$1.416B |
0.00 |
| Trevi Therapeutics (TRVI) |
United States |
$1.380B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$1.375B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.369B |
0.00 |
| AtaiBeckley Inc (ATAI) |
Netherlands |
$1.347B |
0.00 |
| Pharvaris (PHVS) |
Netherlands |
$1.341B |
0.00 |
| EyePoint (EYPT) |
United States |
$1.311B |
0.00 |
| Oxford BioMedica (OXBDF) |
United Kingdom |
$1.309B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$1.282B |
0.00 |
| Rapport Therapeutics (RAPP) |
United States |
$1.280B |
0.00 |
| Novavax (NVAX) |
United States |
$1.264B |
3.21 |
| Biohaven (BHVN) |
United States |
$1.262B |
0.00 |
| AbCellera Biologics (ABCL) |
Canada |
$1.251B |
0.00 |
| Oculis Holding AG (OCS) |
Switzerland |
$1.249B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$1.244B |
0.00 |
| Sana Biotechnology (SANA) |
United States |
$1.244B |
0.00 |
| Palvella Therapeutics (PVLA) |
United States |
$1.231B |
0.00 |
| Septerna (SEPN) |
United States |
$1.226B |
0.00 |
| Immatics (IMTX) |
Germany |
$1.206B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.189B |
163.00 |
| Oric Pharmaceuticals (ORIC) |
United States |
$1.122B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$1.107B |
165.00 |
| Day One Biopharmaceuticals (DAWN) |
United States |
$1.078B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
United States |
$1.070B |
0.00 |
| Zenas BioPharma (ZBIO) |
United States |
$1.070B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
Switzerland |
$1.050B |
0.00 |
| Inhibrx Biosciences (INBX) |
United States |
$1.044B |
0.00 |
| Compass Therapeutics (CMPX) |
United States |
$1.032B |
0.00 |
| Nanobiotix S.A - (NBTX) |
France |
$1.025B |
0.00 |
| Ventyx Biosciences (VTYX) |
United States |
$0.989B |
0.00 |
| CureVac (CVAC) |
Germany |
$0.927B |
0.00 |
| BridgeBio Oncology Therapeutics (BBOT) |
United States |
$0.920B |
0.00 |
| Urogen Pharma (URGN) |
United States |
$0.915B |
0.00 |
| Bicara Therapeutics (BCAX) |
United States |
$0.914B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.908B |
0.00 |
| ArriVent BioPharma (AVBP) |
United States |
$0.904B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.904B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.893B |
0.00 |
| Rapt Therapeutics (RAPT) |
United States |
$0.892B |
0.00 |
| Pacira BioSciences (PCRX) |
United States |
$0.888B |
10.17 |
| GH Research (GHRS) |
Ireland |
$0.882B |
0.00 |
| Iovance Biotherapeutics (IOVA) |
United States |
$0.881B |
0.00 |
| Bright Minds Biosciences (DRUG) |
United States |
$0.875B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$0.863B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.852B |
15.13 |
| MapLight Therapeutics (MPLT) |
United States |
$0.838B |
0.00 |
| Geron (GERN) |
United States |
$0.830B |
0.00 |
| Janux Therapeutics (JANX) |
United States |
$0.825B |
0.00 |
| YD Bio (YDES) |
|
$0.805B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.779B |
0.00 |
| Kura Oncology (KURA) |
United States |
$0.775B |
0.00 |
| BioAge Labs (BIOA) |
United States |
$0.771B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.755B |
0.00 |
| Gyre Therapeutics (GYRE) |
United States |
$0.742B |
96.25 |
| Annexon (ANNX) |
United States |
$0.737B |
0.00 |
| Astria Therapeutics (ATXS) |
United States |
$0.731B |
0.00 |
| Jade Biosciences (JBIO) |
United States |
$0.725B |
0.00 |
| Prime Medicine (PRME) |
United States |
$0.720B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.720B |
10.62 |
| Cytek Biosciences (CTKB) |
United States |
$0.719B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$0.697B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.645B |
0.00 |
| Cullinan Therapeutics (CGEM) |
United States |
$0.630B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.619B |
0.00 |
| Evommune (EVMN) |
United States |
$0.618B |
0.00 |
| EnGene Holdings (ENGN) |
Canada |
$0.618B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$0.587B |
12.51 |
| Ginkgo Bioworks Holdings (DNA) |
United States |
$0.580B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$0.575B |
5.53 |
| Replimune (REPL) |
United States |
$0.573B |
0.00 |
| Invivyd (IVVD) |
United States |
$0.569B |
0.00 |
| LENZ Therapeutics (LENZ) |
United States |
$0.568B |
0.00 |
| Gossamer Bio (GOSS) |
United States |
$0.567B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$0.563B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.562B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.552B |
5.12 |
| SELLAS Life Sciences (SLS) |
United States |
$0.547B |
0.00 |
| LB Pharmaceuticals Inc (LBRX) |
United States |
$0.541B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
United States |
$0.533B |
0.00 |
| Design Therapeutics (DSGN) |
United States |
$0.533B |
0.00 |
| Alto Neuroscience (ANRO) |
United States |
$0.529B |
0.00 |
| Ocugen (OCGN) |
United States |
$0.506B |
0.00 |
| Niagen Bioscience (NAGE) |
United States |
$0.504B |
39.44 |
| Prothena (PRTA) |
Ireland |
$0.498B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.473B |
22.83 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.465B |
0.00 |
| PureTech Health (PRTC) |
United States |
$0.463B |
0.00 |
| Monopar Therapeutics (MNPR) |
United States |
$0.462B |
0.00 |
| Absci (ABSI) |
United States |
$0.459B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.449B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.447B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.447B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.445B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.441B |
0.00 |
| Verastem (VSTM) |
United States |
$0.441B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.440B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$0.440B |
0.00 |
| Anavex Life Sciences (AVXL) |
United States |
$0.433B |
0.00 |
| NovaBridge Biosciences (NBP) |
United States |
$0.422B |
0.00 |
| Entrada Therapeutics (TRDA) |
United States |
$0.414B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.413B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.410B |
0.00 |
| Rocket Pharmaceuticals (RCKT) |
United States |
$0.402B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.397B |
0.00 |
| Cybin (HELP) |
Canada |
$0.392B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
United States |
$0.385B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.383B |
0.00 |
| Kyverna Therapeutics (KYTX) |
United States |
$0.382B |
0.00 |
| Greenwich LifeSciences (GLSI) |
United States |
$0.377B |
0.00 |
| Tectonic Therapeutic (TECX) |
United States |
$0.365B |
0.00 |
| AC Immune (ACIU) |
Switzerland |
$0.364B |
0.00 |
| Allogene Therapeutics (ALLO) |
United States |
$0.362B |
0.00 |
| XOMA Royalty (XOMA) |
United States |
$0.357B |
0.00 |
| Neumora Therapeutics (NMRA) |
United States |
$0.356B |
0.00 |
| Foghorn Therapeutics (FHTX) |
United States |
$0.355B |
0.00 |
| Contineum Therapeutics (CTNM) |
United States |
$0.346B |
0.00 |
| PepGen (PEPG) |
United States |
$0.343B |
0.00 |
| BGM Group (BGM) |
China |
$0.342B |
0.00 |
| Aardvark Therapeutics (AARD) |
United States |
$0.334B |
0.00 |
| Candel Therapeutics (CADL) |
United States |
$0.326B |
0.00 |
| Aura Biosciences (AURA) |
United States |
$0.325B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.321B |
8.62 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.317B |
0.00 |
| Eupraxia Pharmaceuticals (EPRX) |
Canada |
$0.315B |
0.00 |
| GENFIT S.A (GNFTY) |
France |
$0.314B |
0.00 |
| Amarin (AMRN) |
Ireland |
$0.310B |
0.00 |
| Zura Bio (ZURA) |
United States |
$0.305B |
0.00 |
| Lifecore Biomedical (LFCR) |
United States |
$0.303B |
0.00 |
| Immuneering (IMRX) |
United States |
$0.300B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.295B |
4.82 |
| Shattuck Labs (STTK) |
United States |
$0.283B |
0.00 |
| Neurogene (NGNE) |
United States |
$0.280B |
0.00 |
| CAMP4 Therapeutics (CAMP) |
United States |
$0.271B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$0.269B |
0.00 |
| Jyong Biotech (MENS) |
Taiwan |
$0.263B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.261B |
0.00 |
| Rezolute (RZLT) |
United States |
$0.261B |
0.00 |
| Climb Bio (CLYM) |
United States |
$0.257B |
0.00 |
| Adherex Technologies (FENC) |
United States |
$0.255B |
0.00 |
| Prenetics Global (PRE) |
Hong Kong, SAR China |
$0.250B |
0.00 |
| Immix Biopharma (IMMX) |
United States |
$0.249B |
0.00 |
| Orchestra BioMed Holdings (OBIO) |
United States |
$0.235B |
0.00 |
| Adocia (ADOCY) |
France |
$0.231B |
0.00 |
| Nautilus Biotechnology (NAUT) |
United States |
$0.231B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
United States |
$0.228B |
0.00 |
| Nuvectis Pharma (NVCT) |
United States |
$0.218B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$0.216B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$0.215B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.212B |
0.00 |
| Humacyte (HUMA) |
United States |
$0.206B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$0.204B |
0.00 |
| Sagimet Biosciences (SGMT) |
United States |
$0.204B |
0.00 |
| Coherus Oncology (CHRS) |
United States |
$0.201B |
0.00 |
| Cabaletta Bio (CABA) |
United States |
$0.200B |
0.00 |
| Alector (ALEC) |
United States |
$0.199B |
0.00 |
| Alpha Teknova (TKNO) |
United States |
$0.198B |
0.00 |
| Cartesian Therapeutics (RNAC) |
United States |
$0.191B |
0.00 |
| SAB Biotherapeutics (SABS) |
United States |
$0.190B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.188B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.188B |
0.00 |
| Crescent Biopharma (CBIO) |
United States |
$0.174B |
0.00 |
| Milestone Pharmaceuticals (MIST) |
Canada |
$0.173B |
0.00 |
| Molecular Partners AG (MOLN) |
Switzerland |
$0.173B |
0.00 |
| Tiziana Life Sciences (TLSA) |
United Kingdom |
$0.169B |
0.00 |
| Rani Therapeutics Holdings (RANI) |
United States |
$0.169B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.166B |
0.00 |
| Kalaris Therapeutics (KLRS) |
United States |
$0.166B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.165B |
0.00 |
| Codexis (CDXS) |
United States |
$0.161B |
0.00 |
| Quince Therapeutics (QNCX) |
United States |
$0.160B |
0.00 |
| Black Diamond Therapeutics (BDTX) |
United States |
$0.152B |
7.42 |
| VTv Therapeutics (VTVT) |
United States |
$0.147B |
0.00 |
| Vor Biopharma (VOR) |
|
$0.146B |
0.00 |
| Caribou Biosciences (CRBU) |
United States |
$0.146B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.145B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.145B |
0.00 |
| Opus Genetics (IRD) |
United States |
$0.143B |
0.00 |
| Turn Therapeutics (TTRX) |
United States |
$0.142B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.139B |
0.00 |
| MaxCyte (MXCT) |
United States |
$0.138B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.137B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.137B |
0.00 |
| Elicio Therapeutics (ELTX) |
United States |
$0.137B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.135B |
0.00 |
| Whitehawk Therapeutics (WHWK) |
United States |
$0.131B |
0.00 |
| Alpha Cognition (ACOG) |
Canada |
$0.127B |
0.00 |
| Agenus (AGEN) |
United States |
$0.125B |
0.00 |
| Connect Biopharma Holdings (CNTB) |
United States |
$0.124B |
0.00 |
| Eledon Pharmaceuticals (ELDN) |
United States |
$0.124B |
0.00 |
| Actuate Therapeutics (ACTU) |
United States |
$0.124B |
0.00 |
| Tenaya Therapeutics (TNYA) |
United States |
$0.123B |
0.00 |
| Cognition Therapeutics (CGTX) |
United States |
$0.122B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$0.121B |
0.00 |
| Ovid Therapeutics (OVID) |
United States |
$0.113B |
0.00 |
| Acumen Pharmaceuticals (ABOS) |
United States |
$0.113B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.111B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$0.111B |
0.00 |
| Tharimmune (THAR) |
United States |
$0.111B |
0.00 |
| Artiva Biotherapeutics (ARTV) |
United States |
$0.109B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.109B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.108B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.107B |
0.00 |
| Mereo BioPharma Group - (MREO) |
United Kingdom |
$0.107B |
0.00 |
| Seer (SEER) |
United States |
$0.107B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.105B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.103B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.099B |
0.00 |
| Biomea Fusion (BMEA) |
United States |
$0.099B |
0.00 |
| Genelux (GNLX) |
United States |
$0.097B |
0.00 |
| Scilex Holding (SCLX) |
United States |
$0.097B |
0.00 |
| Chrome Holding (MEHCQ) |
United States |
$0.096B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.096B |
0.00 |
| Citius Oncology (CTOR) |
United States |
$0.092B |
0.00 |
| Adagene (ADAG) |
China |
$0.090B |
0.00 |
| EXoZymes (EXOZ) |
United States |
$0.090B |
0.00 |
| OKYO Pharma (OKYO) |
|
$0.090B |
0.00 |
| Annovis Bio (ANVS) |
United States |
$0.085B |
0.00 |
| Coya Therapeutics (COYA) |
United States |
$0.084B |
0.00 |
| BioHarvest Sciences (BHST) |
Canada |
$0.084B |
0.00 |
| Spruce Biosciences (SPRB) |
United States |
$0.080B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.079B |
0.00 |
| MediciNova (MNOV) |
United States |
$0.078B |
0.00 |
| BioStem Technologies (BSEM) |
|
$0.077B |
5.40 |
| XBiotech (XBIT) |
United States |
$0.077B |
0.00 |
| Immunic (IMUX) |
United States |
$0.077B |
0.00 |
| CalciMedica (CALC) |
United States |
$0.076B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.076B |
0.00 |
| ImageneBio (IMA) |
United States |
$0.074B |
0.00 |
| Coeptis Therapeutics Holdings (COEP) |
United States |
$0.073B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.072B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.071B |
0.00 |
| ATyr Pharma (ATYR) |
United States |
$0.069B |
0.00 |
| InflaRx (IFRX) |
Germany |
$0.067B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$0.066B |
0.00 |
| CervoMed (CRVO) |
United States |
$0.066B |
0.00 |
| Tevogen Bio Holdings (TVGN) |
United States |
$0.065B |
0.00 |
| TScan Therapeutics (TCRX) |
United States |
$0.065B |
0.00 |
| Equillium (EQ) |
United States |
$0.065B |
0.00 |
| Adlai Nortye (ANL) |
Cayman Islands |
$0.062B |
0.00 |
| MIRA Pharmaceuticals (MIRA) |
United States |
$0.061B |
0.00 |
| Radiopharm Theranostics - (RADX) |
Australia |
$0.061B |
0.00 |
| Grace Therapeutics (GRCE) |
United States |
$0.056B |
0.00 |
| MiNK Therapeutics (INKT) |
United States |
$0.056B |
0.00 |
| Clene (CLNN) |
United States |
$0.055B |
0.00 |
| Zhengye Biotechnology Holding (ZYBT) |
China |
$0.052B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.052B |
0.00 |
| Aligos Therapeutics (ALGS) |
United States |
$0.051B |
0.00 |
| ABVC BioPharma (ABVC) |
United States |
$0.050B |
0.00 |
| IBio (IBIO) |
United States |
$0.050B |
0.00 |
| Instil Bio (TIL) |
United States |
$0.048B |
0.00 |
| PDS Biotechnology (PDSB) |
United States |
$0.046B |
0.00 |
| Kezar Life Sciences (KZR) |
United States |
$0.045B |
0.00 |
| Passage Bio (PASG) |
United States |
$0.045B |
0.00 |
| NextCure (NXTC) |
United States |
$0.045B |
0.00 |
| Q32 Bio (QTTB) |
United States |
$0.044B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.043B |
0.00 |
| Anebulo Pharmaceuticals (ANEB) |
United States |
$0.043B |
0.00 |
| Jasper Therapeutics (JSPR) |
United States |
$0.043B |
0.00 |
| Tvardi Therapeutics (TVRD) |
United States |
$0.042B |
0.00 |
| BioXcel Therapeutics (BTAI) |
United States |
$0.042B |
0.00 |
| OnKure Therapeutics (OKUR) |
United States |
$0.041B |
0.00 |
| Cingulate (CING) |
United States |
$0.041B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.040B |
0.00 |
| Exicure (XCUR) |
United States |
$0.040B |
0.00 |
| Lantern Pharma (LTRN) |
United States |
$0.039B |
0.00 |
| TuHURA Biosciences (HURA) |
United States |
$0.039B |
0.00 |
| Galecto (GLTO) |
Denmark |
$0.038B |
0.00 |
| Generation Bio (GBIO) |
United States |
$0.038B |
0.00 |
| RenovoRx (RNXT) |
United States |
$0.038B |
0.00 |
| Femasys (FEMY) |
United States |
$0.038B |
0.00 |
| IO Biotech (IOBT) |
Denmark |
$0.037B |
0.00 |
| Celularity (CELU) |
United States |
$0.037B |
0.00 |
| Estrella Immunopharma (ESLA) |
United States |
$0.037B |
0.00 |
| Medicus Pharma (MDCX) |
United States |
$0.035B |
0.00 |
| Elutia (ELUT) |
United States |
$0.035B |
0.00 |
| AN2 Therapeutics (ANTX) |
United States |
$0.034B |
0.00 |
| Xilio Therapeutics (XLO) |
United States |
$0.034B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.033B |
0.00 |
| Atara Biotherapeutics (ATRA) |
United States |
$0.033B |
2.12 |
| Dyadic (DYAI) |
United States |
$0.032B |
0.00 |
| Skye Bioscience (SKYE) |
United States |
$0.031B |
0.00 |
| Rein Therapeutics (RNTX) |
United States |
$0.030B |
0.00 |
| Pluri (PLUR) |
Israel |
$0.030B |
0.00 |
| Barinthus Biotherapeutics (BRNS) |
United States |
$0.030B |
0.00 |
| Alterity Therapeutics - (ATHE) |
Australia |
$0.029B |
0.00 |
| Rallybio (RLYB) |
United States |
$0.029B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.028B |
0.00 |
| Boundless Bio (BOLD) |
United States |
$0.028B |
0.00 |
| Senti Biosciences (SNTI) |
United States |
$0.028B |
0.00 |
| Dare Bioscience (DARE) |
United States |
$0.028B |
0.00 |
| Hyperion DeFi (HYPD) |
United States |
$0.027B |
0.00 |
| Werewolf Therapeutics (HOWL) |
United States |
$0.027B |
0.00 |
| Athira Pharma (ATHA) |
United States |
$0.027B |
0.00 |
| Quantum Biopharma (QNTM) |
Canada |
$0.027B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.027B |
0.00 |
| Genenta Science S.p.A (GNTA) |
Italy |
$0.026B |
0.00 |
| Lixte Biotechnology Holdings (LIXT) |
United States |
$0.026B |
0.00 |
| Intensity Therapeutics (INTS) |
United States |
$0.025B |
0.00 |
| FibroBiologics (FBLG) |
United States |
$0.022B |
0.00 |
| Apollomics (APLM) |
United States |
$0.022B |
0.00 |
| Neuphoria Therapeutics (NEUP) |
United States |
$0.022B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.022B |
0.00 |
| Pasithea Therapeutics (KTTA) |
United States |
$0.021B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.020B |
0.00 |
| Lisata Therapeutics (LSTA) |
United States |
$0.019B |
0.00 |
| Cadrenal Therapeutics (CVKD) |
United States |
$0.019B |
0.00 |
| BioAtla (BCAB) |
United States |
$0.019B |
0.00 |
| Allarity Therapeutics (ALLR) |
United States |
$0.019B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.018B |
0.00 |
| Promis Neurosciences (PMN) |
Canada |
$0.018B |
0.00 |
| Hoth Therapeutics (HOTH) |
United States |
$0.017B |
0.00 |
| Polyrizon (PLRZ) |
Israel |
$0.016B |
0.00 |
| Applied Therapeutics (APLT) |
United States |
$0.016B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.015B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.015B |
0.00 |
| Black Titan (BTTC) |
United States |
$0.015B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.015B |
0.00 |
| Sensei Biotherapeutics (SNSE) |
United States |
$0.015B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.014B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.014B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.013B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.013B |
0.00 |
| Curis (CRIS) |
United States |
$0.012B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.012B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.012B |
0.00 |
| Gelteq (GELS) |
Australia |
$0.012B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.012B |
0.00 |
| NewcelX (NCEL) |
Switzerland |
$0.011B |
0.00 |
| Mainz Biomed (MYNZ) |
Germany |
$0.011B |
0.00 |
| Imunon (IMNN) |
United States |
$0.011B |
0.00 |
| Chemomab Therapeutics (CMMB) |
Israel |
$0.010B |
0.00 |
| GENPREX (GNPX) |
United States |
$0.010B |
0.00 |
| Biorestorative Therapies (BRTX) |
United States |
$0.010B |
0.00 |
| IN8bio (INAB) |
United States |
$0.010B |
0.00 |
| Biofrontera (BFRI) |
United States |
$0.010B |
0.00 |
| Abpro Holdings (ABP) |
United States |
$0.010B |
0.00 |
| Cuprina Holdings (Cayman) (CUPR) |
Singapore |
$0.010B |
0.00 |
| Akari Therapeutics (AKTX) |
United Kingdom |
$0.010B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.009B |
0.00 |
| Moleculin Biotech (MBRX) |
United States |
$0.009B |
0.00 |
| Alzamend Neuro (ALZN) |
United States |
$0.009B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.008B |
0.00 |
| BRIACELL THERAP (BCTX) |
Canada |
$0.008B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.008B |
0.00 |
| GT Biopharma (GTBP) |
United States |
$0.008B |
0.00 |
| Mustang Bio (MBIO) |
United States |
$0.008B |
0.00 |
| Silexion Therapeutics Corp (SLXN) |
Israel |
$0.008B |
0.00 |
| MetaVia (MTVA) |
United States |
$0.007B |
0.00 |
| Advanced Biomed (ADVB) |
United States |
$0.007B |
0.00 |
| Dogwood Therapeutics (DWTX) |
United States |
$0.006B |
0.00 |
| BioAffinity Technologies (BIAF) |
United States |
$0.006B |
0.00 |
| Acurx Pharmaceuticals (ACXP) |
United States |
$0.006B |
0.00 |
| Adial Pharmaceuticals (ADIL) |
United States |
$0.006B |
0.00 |
| Aprea Therapeutics (APRE) |
United States |
$0.006B |
0.00 |
| Sunshine Biopharma (SBFM) |
United States |
$0.006B |
0.00 |
| KALA BIO (KALA) |
United States |
$0.006B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.006B |
0.00 |
| Aspire Biopharma Holdings (ASBP) |
United States |
$0.006B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.005B |
0.00 |
| Revelation Biosciences (REVB) |
United States |
$0.005B |
0.00 |
| VivoSim Labs (VIVS) |
United States |
$0.005B |
0.00 |
| Silo Pharma (SILO) |
United States |
$0.005B |
0.00 |
| Creative Medical Technology Holdings (CELZ) |
United States |
$0.005B |
0.00 |
| Avalon GloboCare (ALBT) |
United States |
$0.005B |
0.00 |
| Propanc Biopharma Inc (PPCB) |
Australia |
$0.005B |
0.00 |
| CNS Pharmaceuticals (CNSP) |
United States |
$0.005B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.004B |
0.00 |
| HCW Biologics (HCWB) |
United States |
$0.004B |
0.00 |
| Alps Group (ALPS) |
United States |
$0.004B |
3.03 |
| GeoVax Labs (GOVX) |
United States |
$0.003B |
0.00 |
| Artelo Biosciences (ARTL) |
United States |
$0.003B |
0.00 |
| Arcadia Biosciences (RKDA) |
United States |
$0.003B |
0.00 |
| Ensysce Biosciences (ENSC) |
United States |
$0.003B |
0.00 |
| Cardio Diagnostics Holdings (CDIO) |
United States |
$0.003B |
0.00 |
| Bone Biologics (BBLG) |
United States |
$0.003B |
0.00 |
| Scinai Immunotherapeutics (SCNI) |
Israel |
$0.003B |
0.00 |
| Onconetix (ONCO) |
United States |
$0.003B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.002B |
0.00 |
| Dermata Therapeutics (DRMA) |
United States |
$0.002B |
0.00 |
| Virax Biolabs Group (VRAX) |
United Kingdom |
$0.001B |
0.00 |
| Biodexa Pharmaceuticals (BDRX) |
United Kingdom |
$0.001B |
0.00 |
| Psyence Biomedical (PBM) |
Canada |
$0.001B |
0.00 |
| GRI Bio (GRI) |
United States |
$0.001B |
0.00 |
| NuCana (NCNA) |
United Kingdom |
$0.000B |
0.00 |
| Aceragen (ACGN) |
United States |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.000B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.000B |
0.00 |
| Clovis Oncology (CLVSQ) |
United States |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.000B |
0.00 |
| CytoMed Therapeutics (GDTC) |
Singapore |
$0.000B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
United Kingdom |
$0.000B |
0.00 |
| NeuroSense Therapeutics (NRSN) |
Israel |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.000B |
0.00 |
| TFF Pharmaceuticals (TFFP) |
United States |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
Switzerland |
$0.000B |
0.00 |
